Fusidic acid suspension twice daily: A new treatment schedule for skin and soft tissue infection in children, with improved tolerability

Journal of Dermatological Treatment

Volumn 15, Issue 3, 2004, Pages 158-163

  Török, Eva ^a   Somogyi, Tihamér ^b   Rutkai, Krisztina ^c   Iglesias, Luis ^d   Bielsa, Isabel ^e  

^a HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^b BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

^c Buda Children's Hospital   (Hungary)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Children; Fusidic acid; Skin and soft tissue infection

Indexed keywords

FUSIDIC ACID; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ANAPHYLACTOID PURPURA; ANOREXIA; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER DYSFUNCTION; MALE; MULTICENTER STUDY; NAUSEA; PERSISTENT INFECTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; SUSPENSION; TREATMENT OUTCOME; VOMITING; BACTERIAL SKIN DISEASE; COMPARATIVE STUDY; DRUG ADMINISTRATION; HUNGARY; INFANT; ORAL DRUG ADMINISTRATION; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SPAIN; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FUSIDIC ACID; HUMANS; HUNGARY; INFANT; MALE; MULTICENTER STUDIES; PROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; SPAIN; STAPHYLOCOCCAL SKIN INFECTIONS; STREPTOCOCCAL INFECTIONS; SUSPENSIONS; TREATMENT OUTCOME;

EID: 85047689893     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630410031909-677     Document Type: Article

References (11)

1. Nordin P, Mobacken HA, Comparison of fusidic acid and flucloxacillin in the treatment of skin and soft-tissue infection. Eur J Clin Res (1994) 5: 97-106.
2. Carr WD, Wall AR, Georgala-Zervogiani S et al, Fusidic acid tablets in patients with skin and soft-tissue infection: a dose finding study. Eur J Clin Res (1994) 5: 87-95.
3. Verbist L, The antimicrobial activity of fusidic acid. J Antimicrob Chemother (1990) 25 (suppl B): 1-5.
4. Blockey NJ, McAllister TA, Antibiotics in acute osteomyelitis in children. J Bone Joint Surg (Br) (1972) 54B; 299-309.
5. Learmonth ID, Dall G, Pollock DJ, Antibiotic therapy in acute infections of bone and joints in children. S Afr Med J (1984) 65: 121-2.
6. Bourget P, Duchamel J-F, Sorensen H et al, Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension. J Clin Pharm Ther (1993) 18: 171-7.
7. Wise R, Pippard M, The diposition of sodium fusidate in man. J Clin Pharm Ther (1975) 4: 615-19.
8. Pharmacokinetics of fusidic acid given in an oral suspension to children. Leo Study FUS 9601 UK. Data on file. LEO Pharma: Ballerup, Denmark.
9. MacGowan AP, Greig MA, Andrews JM et al, Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered on a single oral dose to healthy volunteers. J Antimicrob Chemother (1989) 23: 409-15.
10. Wall ARJ, Menday AP, Fusidic acid and erythromycin in the treatment of skin and soft tissue infection: a double blind study. J Clin Res (2000) 3: 15-28.
11. Morris CDE, Talbot DT, A comparison of sodium fusidate tablets and flucloxacillin capsules in skin and soft tissue infection. J Drug Assessment (2000) 2: 33-46.